| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.89▲ | 7.89▲ | 7.89▲ | 7.94▲ | 7.40▲ |
| MA10 | 7.96▼ | 7.96▲ | 7.98▼ | 7.43▲ | 7.20▲ |
| MA20 | 8.01▼ | 8.00▼ | 8.05▼ | 7.33▲ | 8.40▼ |
| MA50 | 8.08▼ | 7.67▲ | 7.48▲ | 7.26▲ | 8.28▼ |
| MA100 | 7.53▲ | 7.46▲ | 7.40▲ | 8.32▼ | 12.44▼ |
| MA200 | 7.44▲ | 7.22▲ | 7.24▲ | 8.68▼ | 19.13▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.021▼ | -0.043▼ | -0.056▼ | 0.138▲ | 0.042▲ |
| RSI | 48.204▼ | 52.060▲ | 53.897▲ | 59.302▲ | 48.315▼ |
| STOCH | 9.559▼ | 9.559▼ | 30.916 | 80.617▲ | 41.673 |
| WILL %R | -62.500 | -62.500 | -60.440 | -28.989 | -58.685 |
| CCI | -18.349 | -14.395 | -30.149 | 115.022▲ | 52.486 |
|
Monday, March 30, 2026 01:53 PM
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of therapeutics for chronic liver diseases and viral infections. The firm is focused on the ...
|
|
Thursday, March 05, 2026 05:01 PM
(RTTNews) - Aligos Therapeutics, Inc. (ALGS) has reported recent business progress and outlined continued advancement across its pipeline of drug candidates purpose-built for liver and viral diseases.
|
|
Thursday, March 05, 2026 12:00 AM
SOUTH SAN FRANCISCO, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biotechnology company focused on improving patient outcomes through ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/04/26 | 8.25 | 8.58 | 7.8178 | 7.99 | 50,763 |
| 07/04/26 | 8.14 | 8.56 | 7.61 | 7.90 | 48,489 |
| 06/04/26 | 8.00 | 8.635 | 7.94 | 8.09 | 58,705 |
| 02/04/26 | 7.47 | 8.00 | 7.325 | 7.97 | 39,566 |
| 01/04/26 | 7.59 | 7.99 | 7.55 | 7.74 | 62,783 |
| 31/03/26 | 6.73 | 7.57 | 6.73 | 7.43 | 54,837 |
| 30/03/26 | 6.70 | 6.925 | 6.41 | 6.56 | 37,109 |
| 27/03/26 | 7.05 | 7.06 | 6.56 | 6.66 | 56,231 |
| 26/03/26 | 7.06 | 7.36 | 6.8248 | 7.04 | 57,917 |
| 25/03/26 | 6.94 | 7.3775 | 6.765 | 6.96 | 28,398 |
|
|
||||
|
|
||||
|
|